High plasma creatine kinase: Review of the literature and proposal for a diagnostic algorithm

University of Milan, Milano, Lombardy, Italy
Neurological Sciences (Impact Factor: 1.45). 12/2006; 27(5):303-11. DOI: 10.1007/s10072-006-0701-0
Source: PubMed


The condition of persistently high plasma CK levels is frequently encountered in asymptomatic patients with normal neurological examination. This condition may be the unique manifestation of several neuromuscular disorders, whose diagnosis is now possible using new diagnostic techniques. However, even if these patients are intensely investigated, specific diagnoses are not always forthcoming. Because of the lack of a widely accepted diagnostic protocol, hyperCKaemia in asymptomatic subjects is a potentially difficult clinical problem. In this paper we review the literature on conditions associated with variations in plasma CK levels and the literature on investigations carried out in asymptomatic persons with high CK to identify neuromuscular diseases. In the light of these data, and the deliberations of a working group of the Italian Association of Myology, we propose a diagnostic algorithm to guide the diagnostic work-up of persons presenting with persistently high levels of plasma CK. This algorithm has been discussed and approved by the Committee of the Italian Association of Myology.

Download full-text


Available from: Antonietta Citterio, Apr 08, 2014
  • Source
    • "This is especially true since critical re-evaluation of the initial over-promise of such profiling studies and the statistical analysis applied [3] [4], resulting in well-executed Bioinformatics 1553 studies, one of which successfully differentiated serum peptide profiles from three different solid tumor patients and controls [5] [6]. That muscle-specific proteins can be detected in serum as a consequence of muscle damage is already known, and indeed forms the basis of the commonly used creatine kinase test [7]. Extraordinarily high levels of this enzyme in serum are a classical indicator for the presence of neuromuscular disease. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Protein profiling in blood serum by fractionation and MS analysis has been applied in mice to assess its applicability as a fast, economical alternative to current DNA and RNA analyses for diagnosis of neuromuscular disorders. Mass spectra of peptides and proteins were generated using serum from dystrophin-deficient mdx and control mice by WCX ClinProt bead fractionation, followed by MALDI-MS. Double cross-validatory linear discriminant and logistic regression data analysis methods were compared with a new Bayesian logistic regression method. These were evaluated on their ability to discriminate between healthy and dystrophic samples, and to identify the discriminatory peaks in the mass spectra. All three approaches classified the spectra with comparable misclassification rates (between 18.4 and 20.6%), with much overlap between the differential peaks identified between the methods. The differential peak pattern from the Bayesian method was sparser and easier to interpret than from the other two methods, without compromising classifying strength. One of the two main differentiating peaks at m/z 3908 was identified as an N-terminal peptide of coagulation Factor XIIIa, previously identified in human serum. This work underlines the translational aspect of serum protein profiling in mice and supports a further study with serum from patients with neuromuscular disorders.
    Proteomics 04/2008; 8(8):1552-63. DOI:10.1002/pmic.200700857 · 3.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A method to extract the spectral components from spindles of sleep electroencephalograms (EEG) is proposed. High resolution (HR) spectral methods are used which yield better results than Fourier transform (FT) or parametric estimators. A zoom function is produced to reduce their numerical complexity and increase their resolution. The method allows to clearly separate the different spectral components (spindles, K complexes, background activity), and should be considered for spectral analysis of various short EEG transients
    Engineering in Medicine and Biology Society, 1994. Engineering Advances: New Opportunities for Biomedical Engineers. Proceedings of the 16th Annual International Conference of the IEEE; 02/1994
  • [Show abstract] [Hide abstract]
    ABSTRACT: The work presents a predictive dynamic bandwidth allocation (PDBA) scheme that updates the allocated bandwidth periodically to minimize the queue's build-up process. It requires an accurate traffic predictor so we use a two-stage predictor. The first stage includes FARIMA and FNN models running in parallel to predict the traffic data. While FARIMA captures the self-similarity, FNN captures the non-stationarity. The second stage combines the two forecasts using FNN to enhance the prediction accuracy. The performances of the PDBA scheme and the predictors are tested on MPEG and JPEG data. The results show that the two-stage predictor outperforms the individual ones. The proposed PDBA results in lower CLR compared to non-predictive schemes.
    Neural Networks, 2004. Proceedings. 2004 IEEE International Joint Conference on; 08/2004
Show more